SE Asia Stocks-Most fall on lockdown extensions, concerns over COVID-19 drug
Most Southeast Asian stock markets
ended lower on Friday, logging weekly losses, as governments in
the region extended lockdowns and a report raised concerns about
progress in developing a treatment for COVID-19.
Gilead Sciences Inc’s experimental coronavirus
drug, remdesivir, failed its first randomized clinical trial,
according
ended lower on Friday, logging weekly losses, as governments in
the region extended lockdowns and a report raised concerns about
progress in developing a treatment for COVID-19.
Gilead Sciences Inc’s experimental coronavirus
drug, remdesivir, failed its first randomized clinical trial,
according
Posted by Reuters
